Genetic susceptibility to lung cancer

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 2, 2003, Pages 197-204

  Miller, York E ^a,b,c   Fain, Pamela ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Carcinogen metabolism; Genetic susceptibility; Genomic instability; Lung cancer

Indexed keywords

ARTICLE; CANCER RISK; ENVIRONMENTAL FACTOR; GENE LOCUS; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC STABILITY; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; INTRON; LUNG CANCER; PRIORITY JOURNAL;

EID: 0038071727     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39018     Document Type: Article

References (63)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47
2. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-1633
3. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802
4. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105
5. Franklin WA. Pathology of lung cancer. J Thorac Imaging 2000;15:3-12
6. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001;98:13784-13789
7. Anbazhagan R, Tihan T, Bornman DM, et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 1999;59:5119-5122
8. Miller YE, Franklin WA. Molecular events in lung carcinogenesis. Hematol Oncol Clin North Am 1997;11:215-234
9. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull 1996;52:12-21
10. Tong L, Spitz MR, Fueger JJ, Amos CA. Lung carcinoma in former smokers. Cancer 1996;78:1004-1010
11. Sellers TA, Weaver TW, Phillips B, Altmann M, Rich SS. Environmental factors can confound identification of a major gene effect: results from a segregation analysis of a simulated population of lung cancer families. Genet Epidemiol 1998;15:251-262
12. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996;144:554-562
13. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group [see comments]. N Engl J Med 1994;330:1029-1035
14. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease [see comments]. N Engl J Med 1996;334:1145-1149
15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease [see comments]. N Engl J Med 1996;334:1150-1155
16. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study [see comments]. Epidemiology 1994;5:138-146
17. Hemminki K, Lonnstedt I, Vaittinen P, Lichtenstein P. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet Epidemiol 2001;20:107-116
18. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland [see comments]. N Engl J Med 2000;343:78-85
19. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-1050
20. Li FP. The 4th American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention: Phenotypes, Genotypes, and Interventions for Hereditary Cancers. Cancer Epidemiol Biomarkers Prev 1995;4:579-582
21. Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC. Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 1994;52:308-314
22. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 1999;17:253-273
23. Schwartz AG, Siegfried JM, Weiss L. Familial aggregation of breast cancer with early onset lung cancer. Genet Epidemiol 1999;17:274-284
24. Malkinson AM. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res 1992;52(suppl 9):S2670-S2676
25. Malkinson AM. Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp Lung Res 1998;24:541-555
26. Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA 1994;91:1589-1593
27. Malkinson AM. Inheritance of pulmonary adenoma susceptibility in mice. Prog Exp Tumor Res 1999;35:78-94
28. Dragani TA, Hirohashi S, Juji T, et al. Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res 2000;60:5017-5020
29. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Longitudinal methods for describing the relationship between pulmonary function, respiratory symptoms and smoking in elderly subjects: theTucson Study [see comments]. Eur Respir J 1993;6:342-348
30. Lomas DA, Silverman EK. The genetics of chronic obstructive pulmonary disease. Respir Res 2001;2:20-26
31. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987;106:512-518
32. Cohen BH, Diamond EL, Graves CG, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977;2:523-526
33. Malkinson AM, Radcliffe RA, Bauer AK. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 2002;23:411-417
34. Malkinson AM, Bauer A, Meyer A, et al. Experimental evidence from an animal model of adenocarcinoma that chronic inflammation enhances lung cancer risk. Chest 2000;117 (5 suppl 1):228S
35. Yang P, Wentzlaff KA, Katzmann JA, et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999;8:461-465
36. Nicoletto MO, Donach M, De Nicolo A, Artioli G, Banna G, Monfardini S. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev 2001;27:295-304
37. Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002;20:102-109
38. Bowcock AM. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Res Treat 1993;28:121-135
39. Cannon-Albright LA, Skolnick MH. The genetics of familial breast cancer. Semin Oncol 1996;23(1 suppl 2):1-5
40. Peltomaki PT. Genetic basis of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 1994;26:215-219
41. Collins FS. Positional cloning: let's not call it reverse anymore. Nat Genet 1992;1:3-6
42. Collins FS. Identifying human disease genes by positional cloning. Harvey Lect 1990;86:149-164
43. Kinzler KW, Vogelstein B. Cancer-susceptibility genes: gate-keepers and caretakers. Nature 1997;386:761-763
44. Sard L, Accomero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 1999;96:8489-8492
45. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18:2309-2315
46. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649
47. Vessey CJ, Norbury CJ, Hickson ID. Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucleic Acid Res Mol Biol 1999;63:189-221
48. Kolodner RD, Putnam CD, Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science 2002;297:552-557
49. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998;280:1036-1037
50. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9:3-28
51. Stucker I, deWaziers I, Cenee S, et al. GSTM1, smoking and lung cancer: a case-control study. Int J Epidemiol 1999;28:829-835
52. Qingyi W, Lie C, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-1772
53. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 2000;9:1021-1026
54. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999;18:14-20
55. Lerman C, Caporaso N, Main D, et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol 1998;17:56-62
56. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study [see comments]. Science 1998;279:563-566
57. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 2000;92:737-743
58. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000;36:1224-1228
59. Harrela M, Koistinen H, Kaprio J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996;98:2612-2615
60. Hong Y, Pedersen NL, Brismar K, Hall K, de Faire U. Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 1996;81:1791-1797
61. Cohen AJ, Bunn PA, Franklin W, et al. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res 1996;56:831-839
62. Ganju RK, Sunday M, Tsarwhas DG, Card A, Shipp MA. CD10/NEP in non-small cell lung carcinomas: relationship to cellular proliferation. J Clin Invest 1994;94:1784-1791
63. Cohen AJ, Franklin WA, Magill C, Sorenson J, Miller YE. Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients. Am J Respir Crit Care Med 1999;159:907-910